Willow Biosciences Inc. (TSX:WLLW)
Canada
· Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Apr 4, 2025, 9:30 AM EST
Willow Biosciences Company Description
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients.
Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc.
| Country | Canada |
| Founded | 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Chris Savile |
Contact Details
Address: 202, 1201-5th Street SW Calgary, Alberta T2R 0Y6 Canada | |
| Phone | 403 910 5140 |
| Website | willowbio.com |
Stock Details
| Ticker Symbol | WLLW |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA97111B4047 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Chris Savile | President, Director and Chief Executive Officer |
| Travis Doupe | Chief Financial Officer |
| Sanjib Singh Gill L.L.B. | Corporate Secretary |